GL1X · GenesisL1 explorer

Research workbench

Crystal structure of anti- SARS-cov human neutralizing S230 antibody Fab fragment

Analyse Crystal structure of anti- SARS-cov human neutralizing S230 antibody Fab… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6NB8
Type
protein
Length
449 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
S230 antigen-binding (Fab) fragment, heavy chain; S230 antigen-binding (Fab) fragment…
Pockets
4 · best druggability 0.66

Structure

x-ray diffraction · 2 distinct chains · 8% helix, 50% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
HS230 antigen-binding (Fab) fragment, heavy chainprotein23010% helix, 49% strand—
LS230 antigen-binding (Fab) fragment, light chainprotein2195% helix, 51% strand—

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17100.660.7567empty
2610.510.8721empty
3670.330.7620empty
4640.270.7317empty

Interfaces

1 interface between chains.

  • H–L · 2108 Ų buried · 21 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 5 disulfide (disulfide).

Compared structures

  • 6NB8 · Crystal structure of anti- SARS-CoV human neutralizing S230 antibody Fab fragment · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.